An understanding of the role of both pyramidal and interneuronal 5-HT1A heteroreceptors in behavior and how their expression may change in human depression and anxiety may provide important insights into targeting distinct populations of 5-HT1A heteroreceptors by transcriptional modifiers. Here, HTR1A is linked to depressive disorder.